WOLVERINE ASSET MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 19 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q3 2017$5,808,000
-79.3%
3,215,000
-84.5%
0.06%
-82.1%
Q2 2017$28,081,000
+5.9%
20,715,000
+10.7%
0.36%
-13.3%
Q1 2017$26,515,000
+23.6%
18,715,000
+22.7%
0.41%
+48.7%
Q4 2016$21,453,000
+60.4%
15,250,000
+36.9%
0.28%
+38.5%
Q3 2016$13,378,000
+21.0%
11,139,000
-14.1%
0.20%
+19.0%
Q2 2016$11,052,000
+33.2%
12,964,000
+24.3%
0.17%
-28.8%
Q1 2016$8,297,000
-32.3%
10,430,000
-19.3%
0.24%
-10.6%
Q4 2015$12,257,000
-4.9%
12,930,000
-2.4%
0.26%
-13.2%
Q3 2015$12,891,000
-23.7%
13,250,0000.0%0.30%
-20.6%
Q2 2015$16,890,000
+1.6%
13,250,0000.0%0.38%
+15.7%
Q1 2015$16,630,000
+35.0%
13,250,0000.0%0.33%
+37.9%
Q4 2014$12,321,000
+6.4%
13,250,0000.0%0.24%
-0.8%
Q3 2014$11,583,000
-13.5%
13,250,0000.0%0.24%
-17.4%
Q2 2014$13,390,000
-3.3%
13,250,0000.0%0.29%
-1.0%
Q1 2014$13,843,000
-0.3%
13,250,0000.0%0.30%
+7.6%
Q4 2013$13,880,000
+12.3%
13,250,000
+24.0%
0.28%0.0%
Q3 2013$12,364,000
+160.1%
10,685,000
+113.7%
0.28%
+125.4%
Q2 2013$4,754,0005,000,0000.12%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,000,000$53,278,0002.48%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,000,000$6,018,0000.85%
CSS LLC/IL 10,546,000$12,816,0000.62%
Verition Fund Management LLC 3,400,000$4,025,0000.43%
Redmile Group, LLC 4,000,000$4,761,0000.38%
OAKTREE CAPITAL MANAGEMENT LP 19,600,000$23,231,0000.30%
WOLVERINE ASSET MANAGEMENT LLC 11,139,000$13,378,0000.20%
LINDEN ADVISORS LP 2,000,000$2,374,0000.11%
Fernwood Investment Management, LLC 90,000$106,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 5,000,000$5,909,000,0000.09%
View complete list of ARRAY BIOPHARMA INC shareholders